Company Presentation

Argent Biopharma Limited

01 July 2024

 

1 July 2024

Argent BioPharma Ltd.

(Argent BioPharma or the Company)

Company Presentation

Argent BioPharma, an innovative multidisciplinary drug discovery company within the biopharmaceutical sector, announces the publication of its Company Presentation for June 2024 which may be accessed via the following link:

https://www.investi.com.au/api/announcements/rgt/ed231bfb-b84.pdf

-Ends-

Authorised for release by the board of directors, for further information please contact:

Argent BioPharma Roby Zomer CEO & Managing Director [phone] [e-mail]	Argent BioPharma Rowan Harland Company Secretary [phone] [e-mail]
UK IR/PR Advisers  IFC Advisory Graham Herring / Tim Metcalfe / Zach Cohen [phone] [e-mail]	UK Corporate Broker Shore Capital Toby Gibbs / James Thomas / Lucy Bowden [phone]

About Argent BioPharma

Argent BioPharma Limited (the "Company") (ASX: RGT; LSE: RGT; ORCQB: RGTLF) is a Clinical-Stage, Revenue Generating Biopharmaceutical Company committed to providing accessible medical treatments for unmet medical needs, to bridge the gap where medical solutions currently fall short.  The Group focuses on the Multidisciplinary method with Nanotechnology, developing multi-target therapies for comprehensive disease management, especially concerning to the Central nervous system ("CNS") and Immunology treatments.

Follow us through our social media channels:

LinkedIn: Argent BioPharma

Twitter: @ArgentBioPharma

Facebook: Argent BioPharma

 

END